Search

Author/Creator Davids, Matthew S

2. Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study. Issue 10 (October 2021)

Authors:
Davids, Matthew S; Lampson, Benjamin L; Tyekucheva, Svitlana; Wang, Zixu; Lowney, Jessica C; Pazienza, Samantha; Montegaard, Josie; Patterson, Victoria; Weinstock, Matthew; Crombie, Jennifer L; Ng, Samuel Y; Kim, Austin I; Jacobson, Caron A; LaCasce, Ann S; Armand, Philippe; Arnason, Jon E; Fishe...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 10(2021)
Page Start:
1391
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trial. Issue 8 (August 2019)

Authors:
Davids, Matthew S; Brander, Danielle M; Kim, Haesook T; Tyekucheva, Svitlana; Bsat, Jad; Savell, Alexandra; Hellman, Jeffrey M; Bazemore, Josie; Francoeur, Karen; Alencar, Alvaro; Shune, Leyla; Omaira, Mohammad; Jacobson, Caron A; Armand, Philippe; Ng, Samuel; Crombie, Jennifer; LaCasce, Ann S; A...
Journal:
Lancet
Issue:
Volume 6:Issue 8(2019)
Page Start:
e419
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study. Issue 10277 (6th March 2021)

Authors:
Mato, Anthony R; Shah, Nirav N; Jurczak, Wojciech; Cheah, Chan Y; Pagel, John M; Woyach, Jennifer A; Fakhri, Bita; Eyre, Toby A; Lamanna, Nicole; Patel, Manish R; Alencar, Alvaro; Lech-Maranda, Ewa; Wierda, William G; Coombs, Catherine C; Gerson, James N; Ghia, Paolo; Le Gouill, Steven; Lewis, Da...
Journal:
Lancet
Issue:
Volume 397:Issue 10277(2021)
Page Start:
892
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Umbralisib in combination with ibrutinib in patients with relapsed or refractory chronic lymphocytic leukaemia or mantle cell lymphoma: a multicentre phase 1–1b study. Issue 1 (January 2019)

Authors:
Davids, Matthew S; Kim, Haesook T; Nicotra, Alyssa; Savell, Alexandra; Francoeur, Karen; Hellman, Jeffrey M; Bazemore, Josie; Miskin, Hari P; Sportelli, Peter; Stampleman, Laura; Maegawa, Rodrigo; Rueter, Jens; Boruchov, Adam M; Arnason, Jon E; Jacobson, Caron A; Jacobsen, Eric D; Fisher, David C...
Journal:
Lancet
Issue:
Volume 6:Issue 1(2019)
Page Start:
e38
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial. Issue 1 (January 2018)

Authors:
Jones, Jeffrey A; Mato, Anthony R; Wierda, William G; Davids, Matthew S; Choi, Michael; Cheson, Bruce D; Furman, Richard R; Lamanna, Nicole; Barr, Paul M; Zhou, Lang; Chyla, Brenda; Salem, Ahmed Hamed; Verdugo, Maria; Humerickhouse, Rod A; Potluri, Jalaja; Coutre, Steven; Woyach, Jennifer; Byrd, ...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 1(2018)
Page Start:
65
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study. Issue 2 (February 2017)

Authors:
Seymour, John F; Ma, Shuo; Brander, Danielle M; Choi, Michael Y; Barrientos, Jacqueline; Davids, Matthew S; Anderson, Mary Ann; Beaven, Anne W; Rosen, Steven T; Tam, Constantine S; Prine, Betty; Agarwal, Suresh K; Munasinghe, Wijith; Zhu, Ming; Lash, L Leanne; Desai, Monali; Cerri, Elisa; Verdugo...
Journal:
Lancet oncology
Issue:
Volume 18:Issue 2(2017:Feb.)
Page Start:
230
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗